Stratifikatsiya riska razvitiya khronicheskoy bolezni pochek s pomoshch'yu anketirovaniya


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. Estimation of prevalence of albuminuria (Au) as a marker of chronic kidney disease (CKD) and it's risk factors in general population by use of special surveys. Methods. In 1623 general population members (390 (24,0 %) male, 1233 (76,0 %) female, mean age 46 ± 16 years) dipstick urinalysis was performed; urinary albumin > 30 mg/l was considered as Au. Risk factors of CKd were revealed by special survey. Results. AU was found in > 40 % of patients, who applied to Health Centers. According to survey analysis results, the main complaints were peripheral oedema, chest pain, thirst, lack of appetite. 51 % of patients with arterial hypertension had Au. Diabetes or hyperglycemia history was associated with 65,5 % prevalence of Au. AU was found in 44 % overweight patients and in 49 % of patients with obesity. AU was found significantly more often in patients with analgesic abuse, with long history of smoking and in those with low physical activity. Conclusion. Risk of chronic kidney disease in general population can be estimated according to special surveys.

Full Text

Restricted Access

References

  1. Couser W.G, Remuzzi G., Mendi S. et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases //Kidney International. - 2011. - Vol. 80. - P. 1258-1270.
  2. Швецов М.Ю., Бобкова И.Н., Колина И.Б. и др. Современные принципы диагностики и лечения хронической болезни почек: методическое руководство для врачей // Под ред. Шилова Е.М. - 2011. - С. 1-32.
  3. Морозова Т.Е., Шилов Е.М., Белобородова А.Е. Хроническая болезнь почек и метаболический синдром. Возможности фармакологической коррекции // Сеченовский вестник. - 2010. - № 2(2). - С. 56-63.
  4. Zhang Q-L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: Systematic review// BMC Public Health. - 2008. - Vol. 8. - P. 117-124.
  5. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification // Am. J. Kidney Dis. - 2002. - Vol. 39. - P. 1-266.
  6. Coresh J., Astor B.C., Green T. et al. Prevalence of chronic kidney disease and decreased kidney function in the adults US population: Third National Health and Nutrition Examination Survey // Am. J. Kidney Dis. - 2003. -Vol. 41. - P. 1-12.
  7. Levey A.S., Coresh J., Balk E. et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification and stratification // Ann. Intern. Med. - 2003. - Vol. 139. - P. 137-147.
  8. Смирнов А.В., Добронравов В.А., Каюков И.Г. и др. Хроническая болезнь почек: основные принципы скрининга, диагностики, профилактики и подходы к лечению. Национальные рекомендации//Нефрология. - 2012. -№ 16(1). - С. 89-115.
  9. Антонова Т.Н., Бикбов Б.Т., Галь И.Г. и др. К вопросу о распространенности хронической болезни почек среди пожилых лиц в Москве и ее связи с сердечно-сосудистой патологией // Нефрология и диализ. - 2011. - № 13(3). - С. 353-354.
  10. Шалягин Ю.Д., Нагайцева С.С., Швецов М.Ю. и др. Снижение скорости клубочковой фильтрации как маркер хронической болезни почек: частота встречаемости и клинические ассоциации (по данным обследования пациентов терапевтического профиля, госпитализированных в Коломенскую ЦРБ) // Сборник тезисов VII съезда Научного общества нефрологов России. - М. - 2010. - С. 140-141.
  11. Серов В.А., Шутов A.M., Хитева С.В. и др. Возрастные и гендерные особенности распространенности хронической болезни почек среди больных с хронической сердечной недостаточностью // Нефрология и диализ. - 2009. - № 11(4). - С. 332-335.
  12. Coresh J., Selvin E., Stevens L. et al. Prevalence of chronic kidney disease in the United States// JAMA. - 2007. - Vol. 298(17). - P. 2038-2047.
  13. Xue J.L., Ma J.Z., Louis T.A. et al. Forecast of number of patients with endstage renal disease in the United States to the year 2010 // Am. Soc. Nephrol. - 2001. - Vol. 12. - P. 2753-2758.
  14. U.S. Renal Data System: USRDS 2003 Annual Data Report: Atlas or end-stage renal disease in the United States. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
  15. Бикбов Б.Т., Томилина Н.А. Состояние заместительной терапии больных хронической почечной недостаточностью в Российской Федерации в 1998-2007 гг.: Аналитический отчет по данным Российского регистра заместительной почечной терапии // Нефрология и диализ. - 2009. -№ 11(3). - С. 144-233.
  16. Швецов М.Ю., Бобкова И.Н. Хроническая болезнь почек и программа народосбережения России / Под ред. Шилова Е.М. - М. - 2011.
  17. Добронравов В.А., Смирнов А.В., Каюков И.Г. и др. Многогранная альбуминурия: аспекты клинического значения// Нефрология. - 2009. -№ 13(3). - С. 33-38.
  18. NICE Chronic kidney disease. National clinical guideline for early identification and management in adults in primary and secondary care. 2008.
  19. KDIGO 2012: Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
  20. Moynihan R., Glassock R., Doust J. Chronic kidney disease controversy: how expanding definitions are unnecessarily labelling many people as diseased // BMJ. - 2013. - Vol. 29(7). - P. 347-350.
  21. Qaseem A., Hopkins R.H., Sweet D.E. et al. Screening, Monitoring, and Treatment of Stage 1 to 3 Chronic Kidney Disease: A Clinical Practice Guideline From the Clinical Guidelines Committee of the American College of Physicians // Ann. Intern. Med. - 2013. - Vol. 159(12). - Р. 835-847.
  22. Vassalotti J.A., Stevens L.A., Levey A.S. Testing for chronic kidney disease: a position statement from the National Kidney Foundation //Am. J. Kidney Dis. -2007. - Vol. 50(2). - P. 169-180.
  23. Shlipak M.G., Stehman B.C., Fried L.F. et al. The presence of frailty in elderly persons with chronic renalinsufficiency // Am. J. Kidney Dis. - 2004. -Vol. 43(5). - P. 861-867.
  24. Kurella M., Chertow G.M., Fried L.F. et al. Chronic kidney disease and cognitive impairment in the elderly: the health, aging, and body composition study // Journal of the American Society of Nephrology. - 2005. - Vol. 16(7). -P. 2127-2133.
  25. De Jong P.E., Verhave J.C, Pinto-Siestma S.J. et al. Obesity and target organ damage: the kidney // Int. J. Obes. Relat. Metab. Disord. - 2002. - Vol. 26(4). - P. 21-24.
  26. Zavie C.J., Milani R.V. Obesity and cardiovascular disease: the Hyppocrates paradox?// J. Am. Coll. Cardiol - 2003. - Vol. 42. - P. 677-679.
  27. Schaeffher E.S., KurthT.,Curhan G.C. et al. Cholesterol and the risk of renal dysfunction in apparently healthy men // J. Am. Soc. Nephrol. - 2003. - Vol. 14. - P. 2084-2091.
  28. Stuveling E.M., Bakker S.J., Hilige H.X. et al. Biochemical risk markers: a novel area for better prediction of renal risk? // Nephrol. Dial. Transplant. -2005. - Vol. 20. - P. 497-508.
  29. Мухин Н.А., Моисеев В.С., Кобалава Ж.Д. и др. Кардиоренальные взаимодействия: клиническое значение и роль в патогенезе заболеваний сердечно-сосудистой системы и почек // Тер. арх. - 2004. -№ 6. - С. 39-46.
  30. Verhave J.C, Hillege H.Z., Burgerhof G.M. et al. The association between atherosclerotic risk factors and renal function in the general population // Kidney Int. - 2005. - Vol. 67. - P. 1967-1973.
  31. Schiepati A., Remuzzi G. Chronic renal disease as a public health problem: Epidemiology, social and economic implications // Kidney Int. - 2005. - Vol. 68(98). - P. 7-10.
  32. Cirillo M., Stellato D., Laurenzi M., et al. Pulse pressure and isolated systolic hypertention: association with microalbuminuria. The GUBBIO Study Collaborative Research Group // Kidney Int. - 2000. - Vol. 58. -P. 1211-1218.
  33. Gilbetr R., Phillips P., Jerums G. Relationship between ambulatory blood pressure and albuminuria in normal subjects // Am. J. Hypertens. - 1991. -Vol. 4. - P. 959-962. Perdinelli R. Microalbuminuria in Hypertension // Nephron. - 1996. - Vol. 73. - P. 499-505.
  34. Pinto-Siersma S.J., Mulder J., Janssen W.M. et al. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons // Ann. Intern. Med. - 2000. - Vol. 133. - P. 585-591.
  35. Warmoth L., Regalado M.M., Simoni J. et al. Cigarette smoking enhances increased urine albumin excretion as a risk factor for glomerular filtration rate decline in primary hypertension // Am. J. Med. Sci. - 2005. - Vol. 330(3). -P. 111-119.
  36. Orth S.R. Smoking and the kidney // J. Am. Soc. Nephrol. - 2002. - Vol. 13. -P. 1663-1672.
  37. Haroun N.K., Jaar B.G., Hoffman S.C. et al. Risk factors for chronic Kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland // J. Am. Soc. Nephrol. - 2003. - Vol. 14. - P. 2934-2941.
  38. Atkins R.C. The epidemiology ofchronic kidney disease// Kidney Int. - 2005. -Vol. 67(94). - P. 14-18.
  39. Stengel B., Tarver C.M., Powe N.R. et al. Lifestyle factors, obesity and the risk of chronic kidney disease // Epidemiology. - 2003. - Vol. 14(4). -P. 479-487.
  40. Sontrop J.M., Dixon S.N., Garg A.X. et al. Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data //Am. J. Nephrol. - 2013. - Vol. 37(5). - P. 434-442.
  41. Lotan Y., Daudon M., Bruyère F. et al. Impact of fluid intake in the prevention of urinary system diseases: a brief review // Curr. Opin. Nephrol. Hypertens. -2013. - Vol. 22(1). - P. 1-10.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies